FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with trastu… [Video]

Name: FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with trastu... #LungCancerAwareness #LungCancerTreatment #NonSmallCellLungCancer #Adenocarcinoma [Video]
Uploaded: 2024-04-02T17:52:13+00:00
Description: Listen to a soundcast of the May 5, 2021 FDA approval of Keytruda (pembrolizumab) combined with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for first-line treatment of locally advanced unresectable/ metastatic HER2 positive gastric or gastroesophageal junction adenocarcinoma.

Lung Cancer

Post author By Curator
Post date April 2, 2024

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with trastu…

Listen to a soundcast of the May 5, 2021 FDA approval of Keytruda (pembrolizumab) combined with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for first-line treatment of locally advanced unresectable/ metastatic HER2 positive gastric or gastroesophageal junction adenocarcinoma.

Tags Adenocarcinoma, Lung Cancer Awareness, Lung Cancer Treatment, Non Small Cell Lung Cancer

Watch/Read More

FAQs About GiveTaxFree Answered! PART II

GiveTaxFree.Org

givetaxfree.org